(34) studied two nasopharyngeal carcinoma patients with TB reactivation post-pembrolizumab therapy, and revealed that CD137+ CD8+ T cells were abundant in granulomatous tissues (mean density: 78.5 ± 25.1). This evidence concerns the gene TNFRSF9 and nasopharyngeal carcinoma.